Market closedNon-fractional

CEL-SCI/CVM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About CEL-SCI

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Ticker

CVM

Sector

Healthcare

Trading on

AMEX

Industry

Biotechnology

Headquarters

Vienna, United States

Employees

44

CEL-SCI Metrics

BasicAdvanced
$66M
Market cap
-
P/E ratio
-$0.63
EPS
1.04
Beta
-
Dividend rate
$66M
1.04
1.673
1.047
73.623
88.303
-39.26%
-53.51%
-173.88%
4.59
4.65
-2.838
-23.30%
-11.51%

What the Analysts think about CEL-SCI

Analyst Ratings

Majority rating from 1 analysts.
Buy

CEL-SCI Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$0
NaN%
Net income
-$7.2M
7.46%
Profit margin
0.00%
NaN%

CEL-SCI Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 0.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q2 24
Q3 24
Actual
-$0.19
-$0.19
-$0.16
-$0.14
-
Expected
-$0.17
-$0.16
-$0.16
-$0.14
-$0.13
Surprise
11.76%
18.12%
0.00%
0.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for CEL-SCI stock?

CEL-SCI (CVM) has a market cap of $66M as of July 06, 2024.

What is the P/E ratio for CEL-SCI stock?

The price to earnings (P/E) ratio for CEL-SCI (CVM) stock is 0 as of July 06, 2024.

Does CEL-SCI stock pay dividends?

No, CEL-SCI (CVM) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next CEL-SCI dividend payment date?

CEL-SCI (CVM) stock does not pay dividends to its shareholders.

What is the beta indicator for CEL-SCI?

CEL-SCI (CVM) has a beta rating of 1.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell CEL-SCI stock

Buy or sell CEL-SCI stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing